Advertisement

Microglia Activation and Gene Expression of Cytokines in Parkinson’s Disease

  • Makoto Sawada
  • Kazuhiro Imamura
  • Toshiharu Nagatsu
Conference paper
Part of the Advances in Behavioral Biology book series (ABBI, volume 57)

Keywords

Substantia Nigra Dementia With Lewy Body Dopamine Neuron BDNF Level Lewy Body Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Mogi M, Nagatsu T. Neurotrophins and cytokines in Parkinson’s disease. Adv Neurol 1999;80:135–139.PubMedGoogle Scholar
  2. 2.
    Nagatsu T, Mogi M, Ichinose H, et al. Cytokines in Parkinson’s disease. Neurosci News 1999;2:88–90.Google Scholar
  3. 3.
    Nagatsu T, Mogi M, Ichinose H, Togari A. Cytokines in Parkinson’s disease. J Neural Transm Suppl 2000;58:143–151.PubMedGoogle Scholar
  4. 4.
    Nagatsu T. Parkinson’s disease: changes in apoptosis-related factors suggesting possible gene therapy. J Neural Transm 2002;109:731–745.PubMedCrossRefGoogle Scholar
  5. 5.
    Nagatsu T, Sawada M. Inflammatory process in Parkinson’s disease: role for cytokines. Curr Pharmacol Design 2005;11:999–1016.CrossRefGoogle Scholar
  6. 6.
    Hartmann S, Hunot PP, Michel PP, et al. Caspase-3: a vulnerability factor and a final effector in the apoptotic cell death of dopaminergic neurons in Parkinson’s disease. Proc Natl Acad Sci U S A 2000;97:2875–2880.PubMedCrossRefGoogle Scholar
  7. 7.
    Hirsch EC, Hunot S, Damier P, Faucheux B. Glial cells and inflammation in Parkinson’s disease: a role in neurodegeneration? Ann Neurol 1998;44(suppl 1):S115–S120.PubMedGoogle Scholar
  8. 8.
    Hirsch EC, Hunot S, Faucheux B, et al. Dopaminergic neurons degenerate by apoptosis in Parkinson’s disease. Mov Disord 1999;14:383–385.PubMedCrossRefGoogle Scholar
  9. 9.
    Hirsch EC. Inflammatory changes and apoptosis in Parkinson’s disease. Adv Behav Biol 2002;51:259–263.Google Scholar
  10. 10.
    McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson’s disease and Alzheimer’s disease brain. Neurology 1988;38:1285–1291.PubMedGoogle Scholar
  11. 11.
    McGeer PL, McGeer EG. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev 1995;21:195–218.PubMedCrossRefGoogle Scholar
  12. 12.
    Kosaka K. Diffuse Lewy body disease. Neuropathology 2002;20(suppl):73–78.Google Scholar
  13. 13.
    Imamura K, Hashikawa N, Sawada M, et al. Distribution of major histocompatibility class II-positive microglia and cytokine profile of Parkinson’s disease brains. Acta Neuropathol (Berl) 2003;106:518–526.CrossRefGoogle Scholar
  14. 14.
    Vilhardt F, Plastre O, Sawada M, et al. The HIV-1 Nef protein and phagocyte NADPH oxidase activation. J Biol Chem 2002;277:42136–42143.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Makoto Sawada
    • 1
  • Kazuhiro Imamura
  • Toshiharu Nagatsu
  1. 1.Department of Brain Life Science, Research Institute of Environmental MedicineNagoya UniversityNagoyaJapan

Personalised recommendations